Alvarnas JC, Linn YC, Hoppe EG, Negrin RS. Expansion of CD3+CD56+ Cells from Peripheral Blood Progenitor Cells of Patients Undergoing Autologous Hematopoietic Cell Transplantation. Biol Blood Marrow Transplant. 2001;7:216-222.
Alvarnas JC, Negrin RS, Horning SJ, Hu WW, Long GD, Schriber JR, Stockerl-Goldstein K, Tierney K, Wong R, Blume KG, Chao NJ. High-dose therapy with hematopoietic cell transplantation for patients with central nervous system involvement by non-Hodgkin’s lymphoma. Biol Blood Marrow Transplant. 2000;6:352-358.
Alvarnas JC, Hoppe EG, West JJ, Negrin RS. Mechanistic studies of the lysis of human umbilical vein endothelial cells (HUVACS) by cytokine-induced killer cells expanded from peripheral blood mononuclear cells and cord blood. [Abstract # 2882] Blood 1996;87(Supplement 1):
Alvarnas JC, Long GD, Negrin RS, Hu WW, Horning SJ, Tierney DK, Blume KG, Chao NJ. Autologous blood or bone marrow transplantation (BBMT) for patients with non-Hodgkin’s lymphoma involving the central nervous system (CNS). [Abstract 820] Blood 1995;86(Supplement 1):208a. Poster Presentation.
Hope EG, Alvarnas JC, Lu PH, Negrin RS. Distinct mechanisms of tumor and endothelial cell cytotoxicity by NK-T cells: implications for immunotherapy of tumor neoangiogenesis. Submitted.
Doroshow JH, Margolin KA, Chow W, Leong L, Lim D, McNamara M, Morgan R, Shibata S, Somlo G, Twardowski P, Weitzel J, Yen Y, Kogut N, Schriber J, Alvarnas J, Stalter S. High-dose chemotherapy with autologous stem cell rescue (PSCT) for relapsed nonseminomatous germ cell cancer (NSGCT): Effective salvage for poor-risk patients (pts) in first relapse. [Abstract] American Society of Clinical Oncology. Annual Meeting 2002.
Morgan RJ, Doroshow JH, Leong L, Schriber J, Shibata S, Forman S, Hamasaki V, Margolin K, Somlo G, Alvarnas J, McNamara M, Longmate J, Raschko J, Chow W, Vasilev S, McGonigle K, Yen Y. Phase II trial of high-dose intravenous doxorubicin, etoposide and cyclophosphamide with autologous stem cell support in patients with residual or responding recurrent ovarian cancer. Bone Marrow Transplant. 2001;28:859-863.
Somlo G, Doroshow JH, Synold T, Longmate J, Reardon D, Chow W, Forman SJ, Leong LA, Margolin KA, Morgan Jr. RJ, Raschko JW, Shibata SI, Tetef ML, Yen Y, Kogut N, Schriber J and Alvarnas J. High-dose paclitaxel in combination with doxorubicin, cyclophosphamide and peripheral blood progenitor cell rescue in patients with high-risk primary and responding metastatic breast carcinoma: toxicity profile, relationship to paclitaxel pharmacokinetics and short-term outcome. Brit J Cancer. 2001;84:1591-1598.
Somlo G, Scalia M, Frankel P, Forman S, Damon L, Chow W, Margolin K, Leong L, Alvarnas J, Twrdowski P, McNamara M, Molina M, Morgan R, Shibata S and Doroshow J. Tandem high-dose chemotherapy as adjuvant in stage IIIb inflammatory breast cancer. Abstract. 24th Annual San Antonio Breast Cancer Symposium. 2001.
Somlo G, Doroshow JH, Leong L, Margolin K, Morgan R, Raschko K, Chow W, Shibata S, Tetef M, Yen Y, Molina A, Alvarnas J, Kogut N, Schriber J, Forman S. Can high-dose chemotherapy and peripheral blood progenitor rescue (HDCT) improve survival of patients (PTS) with stage IIIB inflammatory breast carcinoma (IBC): progression-free (PFS) and overall survival (OS) and predictors of outcome in 74 pts. Abstract 385. American Society of Clinical Oncology, Annual Meeting, May 1999
Schriber JR, Wetzler M, Herzig GP, Slack JL, Alvarnas JC, Abramowski C, Tucker GM, Fay JW, Fehniger TA. Outpatient interleukin 2 (IL2) following stem cell transplantation (SCT) increases NK cell number and cytotoxicity. American Society of Hematology, Annual Meeting, December 1998
Hoppe EG, Alvarnas J, West J, Negrin RS. Upregulation of a 46 kDa collagen binding protein correlates with protection of HUVEC cells in-vitro against cytolysis by CD3+56+ CTL and IL-2 stimulated natural killer cells. [Abstract # 1277] Blood 1995;86(Supplement 1):322a.
This is a partial list. Full publications list available upon request. Information on this page may be self-reported and is subject to change at any time. Last updated: 07/08.